Cytotoxic T lymphocytes carrying a pattern recognition protein Tag7 can detect evasive, HLA-negative but Hsp70-exposing tumor cells, thereby ensuring FasL/Fas-mediated contact killing
Open Access
- 15 September 2007
- journal article
- Published by American Society of Hematology in Blood
- Vol. 110 (6), 1997-2004
- https://doi.org/10.1182/blood-2006-12-064444
Abstract
Within the broad problem of host immune surveillance versus tumor immune evasion, a most intriguing question is how the cellular immunity can cope with cancerous cells that have gotten rid of the classical antigen-presenting machinery. One such option stems from (1) the fact that HLA loss is often attended with expression of Hsp70 on the tumor cell surface, and (2) our findings that human lymphocytes express a protein Tag7 (also known as PGRP-S) capable of tight and specific interaction with cognate Hsp70. Here we show that a subpopulation of human CD4+CD25+ lymphocytes, obtained either in culture as lymphokine-activated killers or directly from healthy donors, carry Tag7 and FasL on their surface and can indeed kill the HLA-negative tumor-derived cells K562 and MOLT-4 that expose Hsp70 and Fas. The primary binding of lymphocyte Tag7 to target-cell Hsp70 is very specific (eg, it is blocked by preincubating either cell with minimal peptides from the “partner” protein), and secures cell contact indispensable for subsequent FasL/Fas-triggered apoptosis. Unrelated to natural killer cell action or the putative role of Hsp as an antigen-presenting substitute, this novel mechanism is rather a backup analog of orthodox (CD8+) target recognition (Tag7 acting as built-in T-cell receptor and Hsp70 itself as ligand).Keywords
This publication has 35 references indexed in Scilit:
- Anti-lymphoma effect of γδ T cellsLeukemia & Lymphoma, 2005
- Strategies of Tumor Immune EvasionBioDrugs, 2005
- Gene transfer approaches in cancer immunotherapyGene Therapy, 2004
- MHC class I down-regulation: tumour escape from immune surveillance? (review).International Journal of Oncology, 2004
- Immunotherapy with autologous tumor cells engineered to secrete Tag7/PGRP, an innate immunity recognition moleculeThe Journal of Gene Medicine, 2004
- Peptidoglycan Recognition Protein Tag7 Forms a Cytotoxic Complex with Heat Shock Protein 70 in Solution and in LymphocytesJournal of Biological Chemistry, 2004
- Peptidoglycan recognition proteins (PGRPs)Molecular Immunology, 2003
- The immune response of DrosophilaNature, 2003
- Hsp70 plasma membrane expression on primary tumor biopsy material and bone marrow of leukemic patientsCell Stress and Chaperones, 2000
- How do cytotoxic lymphocytes kill their targets?Current Opinion in Immunology, 1998